Omarigliptin alleviates cognitive dysfunction in Streptozotocin-induced diabetic mouse

Increasing epidemiological evidence supports the strong association between diabetes mellitus (DM) and cognitive dysfunction. Omarigliptin is a long-acting dipeptidyl peptidase 4 (DPP-4) inhibitor for the treatment of diabetes. However, the effect of Omarigliptin in diabetes-associated cognitive dys...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoyan, Yin, Ying, Li, Wenfeng, Li, Shanshan, Zhang, Dandan, Liu, Zehong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161942/
https://www.ncbi.nlm.nih.gov/pubmed/35389830
http://dx.doi.org/10.1080/21655979.2022.2055699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161942/
https://www.ncbi.nlm.nih.gov/pubmed/35389830
http://dx.doi.org/10.1080/21655979.2022.2055699

Ejemplares similares